viewMedlab Clinical Ltd

Media Corp. - Transaction in Own Shares

Media Corporation PLC Media Corporation PLC Media Corp (AIM:MDC), a leading internet media and advertising Group, announces that on 22 July 2008 the Group purchased 230,000 ordinary shares of 1p each in the capital of the Group at a price of 2.38 pence per share. Media Corp intends to hold the purchased shares in treasury. The purchase equates to approximately 0.083% of the Group's current total issued share capital. Following this transaction, Media Corp has 278,127,298 ordinary shares in issue and 13,800,000 ordinary shares in treasury. The total number of voting rights in, and the figure to be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or changes to their interest in, Media Corp under the FSA's Disclosure and Transparency Rules is 278,127,298. For further information please contact: Media Corporation plc Justin Drummond, Chief Executive Nilesh Jagatia, Group Finance Director +44 (0)20 7618 9000 Canaccord Adams Limited Mark Williams, Managing Director +44 (0)20 7050 6500 Notes to editors: Listed on the AIM market of the London Stock Exchange, Media Corp is a leading internet media and advertising group focused on website publishing and online advertising. The Group has two principal divisions: Advertising Network - Formed in 1996, Eyeconomy specialises in mass reach campaigns to over 32 Million unique consumers per month via its own proprietary ad-serving and tracking technology for clients including AOL, Dell and American Express. www.eyeconomy.co.uk Website Publishing - Media Corp has a diverse publishing division specializing in online media. Our impressive portfolio of websites includes a number of market leading sites including www.gambling.com, www.onthebox.com www.sport.co.uk, www.creditcardexpert.co.uk and www.flightcomparison.co.uk. www.mediacorpplc.com Media Corporation PLC

Quick facts: Medlab Clinical Ltd

Price: 0.39

Market: ASX
Market Cap: $83.99 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Medlab Clinical forges ahead in new vitamin trials for chronic illnesses

Medlab Clinical Ltd (ASX:MDC) chief executive officer Sean Hall tells Proactive Investors how the company is tapping into new areas of its “therapeutic toolkit” to better assist those with chronic health conditions.   Hall says there has been a shortfall in the standard of...

on 8/5/19